Sandra Bauer Selected Research

Immunosorbents

1/2016

Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sandra Bauer Research Topics

Disease

11	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 01/2022 - 08/2015
7	Infections 05/2021 - 09/2011
5	Neoplasms (Cancer) 01/2021 - 04/2006
3	COVID-19 01/2022 - 01/2020
3	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 02/2016
3	Colorectal Neoplasms (Colorectal Cancer) 05/2009 - 04/2006
2	Inflammation (Inflammations) 01/2021 - 09/2012
2	Lymphoma (Lymphomas) 01/2016 - 05/2009
2	Neoplasm Metastasis (Metastasis) 10/2008 - 04/2006
1	Reinfection 05/2021
1	Hypoxia (Hypoxemia) 01/2018
1	Glioma (Gliomas) 01/2018
1	Immune System Diseases (Immune Disorders) 01/2018
1	Myocarditis (Carditis) 01/2018
1	Virus Diseases (Viral Diseases) 01/2018
1	Infectious Mononucleosis (Glandular Fever) 01/2017
1	Epstein-Barr Virus Infections 01/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2016
1	Multiple Sclerosis 01/2016
1	Human Influenza (Influenza) 01/2016
1	Common Variable Immunodeficiency 01/2016
1	Central Nervous System Diseases (CNS Diseases) 01/2016
1	Stomach Diseases 02/2013
1	of Swine Transmissible Gastroenteritis 09/2011
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2011
1	Wilms Tumor (Wilm's Tumor) 01/2011
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2009
1	Hydatidiform Mole (Molar Pregnancy) 04/2006
1	Pre-Eclampsia (Preeclampsia) 02/2004
1	Rupture 12/2002
1	Premature Obstetric Labor (Premature Labor) 12/2002
1	Melanoma (Melanoma, Malignant) 05/2002

Drug/Important Bio-Agent (IBA)

7	Peptides (Polypeptides)IBA 01/2021 - 05/2002
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2008
4	AutoantibodiesIBA 08/2021 - 02/2016
4	EnzymesIBA 08/2021 - 01/2016
4	AntibodiesIBA 01/2021 - 02/2016
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 08/2021 - 02/2016
3	CytokinesIBA 01/2021 - 05/2009
3	Chemokine ReceptorsIBA 10/2008 - 04/2006
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 08/2021 - 04/2021
2	Immunoglobulin G (IgG)IBA 05/2021 - 08/2015
2	Adrenergic Agents (Adrenergic Drugs)IBA 01/2021 - 02/2016
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 05/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 02/2004
2	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 01/2018 - 02/2016
2	LigandsIBA 10/2008 - 04/2006
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2007 - 05/2002
1	Monoclonal AntibodiesIBA 01/2022
1	Therapeutic UsesIBA 05/2021
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020
1	Interferon Regulatory FactorsIBA 01/2020
1	Long Noncoding RNAIBA 01/2018
1	Poly I-CIBA 01/2018
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2018
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2018
1	Cholinergic ReceptorsIBA 02/2016
1	Cholinergic Agents (Cholinergics)IBA 02/2016
1	Inactivated VaccinesIBA 01/2016
1	ImmunosorbentsIBA 01/2016
1	OsteopontinIBA 01/2016
1	Toll-Like Receptor 1IBA 02/2013
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 09/2011
1	Sialic AcidsIBA 09/2011
1	Neuraminidase (Sialidase)IBA 09/2011
1	HLA-A Antigens (HLA-A)IBA 05/2009
1	HLA-A*02:01 antigenIBA 05/2009
1	EpitopesIBA 05/2009
1	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2009
1	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 03/2007
1	Carcinoembryonic AntigenIBA 04/2006
1	beta CateninIBA 04/2006
1	Plasminogen Activator Inhibitor 1IBA 02/2004
1	CRF receptor type 2IBA 12/2002
1	Monophenol Monooxygenase (Tyrosinase)IBA 05/2002

Therapy/Procedure

1	Aftercare (After-Treatment) 01/2022
1	Therapeutics 09/2012
1	Immunotherapy 05/2009